Lumora article "Developing a bioluminescent assay for viral load monitoring in HIV" featured in May 2012 edition of IVD Technology

14th May 2012


The May edition of IVD Technology has just been published and carries the article "Developing a bioluminescent assay for viral load monitoring in HIV". It describes how the new technology could address the significant and so far unmet needs of the developing world for HIV viral load management. The article is authored by Laurence Tisi, Olga Gandelman and Paul Weinberger. The magazine is available to reigstered recipients via the following link:

http://dc.cn.ubm-us.com/i/64896

Click here to download a reprint of the article


About Lumora

Lumora specialises in the development of robust, affordable and easy-to use molecular diagnostics systems based on its proprietary 'BART' technology. The company was founded in 2002 as a spin-out from the Institute of Biotechnology at the University of Cambridge, and now employs 13 people with a wide range of experience and operates from a dedicated, 6,100 sq ft facility. The scientific team of nine includes four senior post-docs as well as IVD industry experienced process development staff. Capabilities include bioinformatics, primer design, test optimisation, test evaluation, protocol optimisation, reagent stabilisation and scale-up guidance. Lumora has microbiology experts in-house and facilities to deal with many common pathogens.